
Talis Biomedical Corporation TLIS
Quarterly report 2024-Q2
added 08-19-2024
Talis Biomedical Corporation DSO Ratio 2011-2026 | TLIS
Annual DSO Ratio Talis Biomedical Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.6 | 18.6 | 4.08 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.6 | 4.08 | 17.8 |
Quarterly DSO Ratio Talis Biomedical Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 35 | - | 175 | 51.8 | 16.3 | - | 24.8 | 207 | 39.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 207 | 16.3 | 78.6 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
40.7 | $ 2.18 | 1.87 % | $ 3.4 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 10.73 | 2.98 % | $ 1.45 B | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Butterfly Network
BFLY
|
76.1 | $ 4.14 | 5.88 % | $ 876 M | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 8.52 | 1.67 % | $ 612 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 36.66 | -2.0 % | $ 1.14 B | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 12.71 | 0.87 % | $ 1.91 B | ||
|
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.69 | 6.15 % | $ 37.6 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.16 | 4.95 % | $ 155 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 71.56 | 2.54 % | $ 106 B | ||
|
Establishment Labs Holdings
ESTA
|
123 | $ 65.03 | 2.43 % | $ 1.93 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
InMode Ltd.
INMD
|
5.36 | $ 13.64 | 1.56 % | $ 882 M | ||
|
ClearPoint Neuro
CLPT
|
46.1 | $ 11.14 | 1.0 % | $ 301 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.34 | 0.77 % | $ 21.6 M | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
237 | $ 18.42 | - | $ 121 M | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 2.19 | -0.23 % | $ 1.33 M | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 61.86 | 0.7 % | $ 3.37 B | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
MiMedx Group
MDXG
|
57.3 | $ 4.5 | 1.93 % | $ 665 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 111.24 | 1.17 % | $ 194 B | ||
|
Delcath Systems
DCTH
|
48.5 | $ 9.82 | 0.05 % | $ 352 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 265.0 | 1.44 % | $ 7.48 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.27 | 2.89 % | $ 714 M | ||
|
AxoGen
AXGN
|
40.7 | $ 32.87 | 0.08 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
86.7 | $ 175.45 | 3.54 % | $ 13.1 B | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 33.48 | 2.18 % | $ 4.99 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
111 | $ 3.86 | 5.07 % | $ 159 M | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 17.24 | 0.76 % | $ 404 M |